News Archives - Page 7 of 88

WednesdayAug 21, 2024 11:25 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary small molecule drug candidates, today announced its receipt of three patents granted in the U.S., strengthening its patent portfolio. The issued patents include one for its formulation and method of use in the treatment of epidermolysis bullosa and related connective tissue disorders, one for biosynthesis manufacturing processes and one for an ocular drug delivery formulation. As of August 20, 2024, InMed has a total of 13 patent families covering new chemical entities, formulations, manufacturing processes and methods of use. “We are pleased to…

TuesdayAug 20, 2024 2:54 pm

TinyGemsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’

ECGI Holdings (OTC: ECGI), a diversified holding company with a unique portfolio in viticulture, hospitality and luxury fashion, is reporting on the success of its Allon equestrian apparel line during the American Equestrian Trade Association (“AETA”) International trade show, which was held in Dallas. According to the company, the launch, which included a range of show coats, show shirts, breeches, safety vest covers and jewelry, “drew significant attention from key retailers.” The company called the trade show a “pivotal moment” for Allon, noting that the line continues to gain momentum in the highly competitive equestrian market. “The positive feedback we…

TuesdayAug 20, 2024 11:23 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced that recent data from preclinical studies confirms INM-901, a proprietary small molecule drug candidate, as an oral formulation that will be utilized in the company’s development programs for Alzheimer’s disease. The data shows that the INM-901 formulation can be administered orally and maintains similar drug exposure and therapeutic levels as intraperitoneal (“IP”) delivery over a 24-hour period in the brain. The announcement noted that the oral delivery method offers potential advantages such as lower treatment delivery costs. “We are…

TuesdayAug 13, 2024 1:42 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases Financial Results, Business Update

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, is providing a financial and business report for the three- and nine-month period ended June 30, 2024. Highlights of the report indicate a positive stockholders’ equity of $53 million and total assets of $192 million. The report also noted, among other key milestones, that the company has secured a substantial $250 million new financing commitment; has announced a lease program for Class 1 EV cargo vans created with a focus on individuals, small businesses and fleets; and has received an order for 20 Mullen-GOs from GAMA (“GAMA”), one of its international distributors. In…

MondayAug 12, 2024 12:35 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives Follow-On Order from UVA

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for one Mullen One, a Class 1 EV cargo van, from the University of Virginia for the school’s fleet of commercial vehicles. According to the announcement, the order, which follows an earlier purchase the university made last year, will be fulfilled by Mullen’s commercial retail dealer partner, Randy Marion Automotive Group (“RMA”). The company also noted that it recently received a $7.7 million, 180-vehicle order from its dealer partner Eco Auto. The two orders represent a growing demand for Mullen's electric commercial vehicles, the announcement pointed out. The…

WednesdayAug 07, 2024 3:52 pm

TinyGemsBreaks – Pineapple Financial Inc. (NYSE American: PAPL) Spotlighted in RazorPitch Article Highlighting Tremendous Growth Opportunities in Canada’s Unique Mortgage Market

Pineapple Financial (NYSE American: PAPL), a digital mortgage company focused on providing Canadian mortgage brokers with the systems, tools, and technologies they need to provide home buyers and mortgage seekers with a more digital customer experience, has been featured in a RazorPitch article. With Canada’s unique mortgage market requiring holders to refinance after every five years, Pineapple Financial offers investors the perfect way to capitalize on this opportunity. According to the article, the company’s technology is designed and geared towards Canadian mortgage brokers, a very fast-growing channel of origination. Over 75% of half of all mortgages that Canadians are…

TuesdayAug 06, 2024 10:21 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Shares Update from CEO

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update from CEO and chairman David Michery. According to the update, the company believes it has a strong foundation for future growth in EV sales based on the value of its total assets and cash position. Mullen highlighted the $250 million in new financing commitments it has secured to accelerate its growth plan, the expansion of its sales and distribution reach, the receipt of new orders, the delivery of vehicles, and negotiations to expand its customer base and market share. In addition, Mullen noted that it is…

FridayAug 02, 2024 10:53 am

TinyGemsBreaks – Better Choice Company (NYSE American: BTTR) Closes on $5M Public Offering

Better Choice Company (NYSE American: BTTR), a pet health and wellness company, has closed on its public offering. The offering consisted of 639,000 shares of common stock as well as prefunded warrants to purchase 1,028,000 shares of its common stock. According to the announcement, each share of common stock and prefunded warrant was sold at $3 per share (inclusive of the prefunded warrant exercise price), resulting in gross proceeds of approximately $5 million, before underwriting discounts and offering expenses were deducted. The announcement also noted that Better Choice granted the underwriters a 45-day option to purchase up to an additional…

MondayJul 29, 2024 12:58 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Enters Definitive Agreement to Embark on New Journey Together with Koito

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, is announcing the signing of a definitive agreement. The agreement provides for the acquisition of Cepton by Koito Manufacturing Co. Ltd. (TSE: 7276), a leading automotive tier one supplier. Specifically, Koito will acquire all the outstanding capital stock of Cepton not owned by itself in an all-cash transaction, with Cepton stockholders receiving $3.17 per share in cash. According to the announcement, the proposed transaction has been approved by each company’s Board of Directors and recommended to Cepton’s stockholders by Cepton’s Board of Directors. It is expected…

WednesdayJul 17, 2024 3:23 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Noteworthy Findings from Interim Results of Ongoing Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the receipt of interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1. The company noted that the results have already produced several noteworthy findings. According to the announcement, unlimited food and water have been provided to the animals for the entire duration of the study. During the initial acclimation phase, which spanned 34 days before the beginning of dosing, the animals gained 10.9% body weight on average. During the subsequent 28 days of DehydraTECH-processed drug therapy dosing, all test…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News